CMRX - CDC outlines stocks of vaccines available for monkeypox treatment

The CDC said that it has over 1K doses of the Jynneos vaccine, made by Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), in the national stockpile and will release some of it soon, Reuters reported. Jynneos is the only U.S. FDA vaccine approved for monkeypox. In addition, the U.S. has more than 1M doses of the ACAM2000 vaccine, made by Emergent BioSolutions (NYSE:EBS). Although a smallpox vaccine, ACAM2000 could potentially be used against monkeypox. In Monday afternoon trading, Emergent is up ~4% but Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY) is down ~8%. Smallpox drugmakers SIGA Technologies (SIGA) and Chimerix (CMRX) are also down. On Monday, the European Centre for Disease Prevention and Control reported 67 confirmed cases in nine EU member countries. In a risk assessment, the agency said the risk of monkeypox spread was high in those having multiple sexual partners. In the U.S., there is one confirmed monkeypox cases, in Massachusetts. However, there are suspected cases

For further details see:

CDC outlines stocks of vaccines available for monkeypox treatment